Cord blood from At-Risk newborns collected to advance sickle cell research
NCT ID NCT03876821
First seen Nov 18, 2025 · Last updated Apr 29, 2026 · Updated 13 times
Summary
This study collected umbilical cord blood from 44 newborns whose mothers had the sickle cell trait. The goal was to study the blood cells and develop better ways to prepare, gene-modify, and preserve them for future treatments. No direct treatment was given to participants; the work was done in the lab to advance scientific understanding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHSF
Corbeil-Essonnes, 91106, France
Conditions
Explore the condition pages connected to this study.